Vytone | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
CDMO Prospector
- Demo Dashboard
Drugs in Dev.
News
Blog
Market Place
Login

Vytone
US Patents

PharmaCompass Sponsored Ads

Contact Supplier

Strides Hydrocortisone

Contact Supplier

Suanfarma, at the Core of a Better Life.

Contact Supplier

PharmaCompass Sponsored Ads

Contact Supplier

Symbiotech Hydrocortisone

Contact Supplier

Laboratorium Ofichem, offering a flexible, high-tech environment to produce broad range of APIs for Human & Vet pharmaceutical markets.

Contact Supplier

Vytone

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

85 API Suppliers, 29 USDMF, 14 CEP/COS, 6 JDMF, 12 EU WC, 10 KDMF, 40 NDC API, 1 VMF, 31 Listed Suppliers, $ API Reference Price

85 API Suppliers
29 USDMF
14 CEP/COS
6 JDMF
12 EU WC
10 KDMF
40 NDC API
1 VMF
31 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

23 Drugs in Development

23 Drugs in Development

FINISHED DOSAGE FORMULATIONS

389 FDF Dossiers, 234 FDA Orange Book, 83 Europe, 14 Canada, 8 Australia, 27 South Africa, 23 Listed Dossiers

389 FDF Dossiers
234 FDA Orange Book
83 Europe
14 Canada
8 Australia
27 South Africa
23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%, CREAM;TOPICAL - 5%;1%, OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 1%, LOTION;TOPICAL - 2%, TABLET;ORAL - 10MG, TABLET;ORAL - 20MG, TABLET;ORAL - 5MG

SUSPENSION/DROPS;OTIC - EQ 0.2% BASE;1%
CREAM;TOPICAL - 5%;1%
OINTMENT;TOPICAL - 400 UNITS/GM;1%;EQ 3.5MG BASE/GM;5,000 UNITS/GM **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
CREAM;TOPICAL - 1%
LOTION;TOPICAL - 2%
TABLET;ORAL - 10MG
TABLET;ORAL - 20MG
TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 4 Rochem International Inc, 8 SPI Pharma, 17 DKSH, 1 Pharm-RX Chemical, 6 Gangwal Healthcare, 24 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 4 Pfanstiehl, 22 Actylis, 1 Aeon Procare, 7 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 42 BASF, 3 BioSpectra, 4 CD Formulation, 1 Clariant, 15 Corel Pharma Chem, 7 DFE Pharma, 3 Esteem Industries, 6 Finar, 16 Gangwal Chemicals, 2 Hayashibara, 2 Ideal Cures, 4 Ingredion Pharma Solutions, 19 Kerry, 3 Keval Exports, 9 Lubrizol Life Science Health, 17 Microlex e.U, 3 Nanjing Bold Chemical, 2 Nippon Fine Chemical, 2 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 1 Novo Excipients, 2 Pharmatrans-Sanaq, 7 Pluviaendo, 4 Prachin Chemical, 33 Roquette, 21 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 10 Sigachi Industries, 5 Silverline Chemicals, 1 Symrise, 2 Valens Pharmachem, 5 Vasa Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

92 Topical, 60 Solubilizers, 59 Thickeners and Stabilizers, 57 Fillers, Diluents & Binders, 43 Parenteral, 36 Direct Compression, 33 Granulation, 30 Emulsifying Agents, 28 Lubricants & Glidants, 27 Coating Systems & Additives, 27 Disintegrants & Superdisintegrants, 23 Controlled & Modified Release, 20 Film Formers & Plasticizers, 20 Surfactant & Foaming Agents, 18 Taste Masking, 14 Co-Processed Excipients, 12 Chewable & Orodispersible Aids, 10 Rheology Modifiers, 5 API Stability Enhancers, 2 Coloring Agents, 1 Soft Gelatin

92 Topical
60 Solubilizers
59 Thickeners and Stabilizers
57 Fillers, Diluents & Binders
43 Parenteral
36 Direct Compression
33 Granulation
30 Emulsifying Agents
28 Lubricants & Glidants
27 Coating Systems & Additives
27 Disintegrants & Superdisintegrants
23 Controlled & Modified Release
20 Film Formers & Plasticizers
20 Surfactant & Foaming Agents
18 Taste Masking
14 Co-Processed Excipients
12 Chewable & Orodispersible Aids
10 Rheology Modifiers
5 API Stability Enhancers
2 Coloring Agents
1 Soft Gelatin

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 49 News #PharmaBuzz

1 Data Compilation #PharmaFlow
49 News #PharmaBuzz

GLOBAL SALES INFORMATION

38 US Medicaid Prescriptions, 91 Regulatory FDF Prices, 1 Annual Reports

38 US Medicaid Prescriptions
91 Regulatory FDF Prices
1 Annual Reports

MARKET PLACE

34 APIs, 17 FDF Dossiers

34 APIs
17 FDF Dossiers

PATENTS & EXCLUSIVITIES

12 US Patents

12 US Patents

REF. STANDARDS & IMPURITIES

4 EDQM, 3 JP, 5 Others

4 EDQM
3 JP
5 Others

ANALYTICAL

2 BioAnalytical Methods, 4 Analytical Methods

2 BioAnalytical Methods
4 Analytical Methods

$ API Ref.Price (USD/KG) : 406 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

12 All

01 12ETON

filter Patent Number Reset all filters

12 All

01 49649280

02 49675559

03 49717740

API Patent Reset all filters

12 All

01 12Blank

filter FDF Patent Reset all filters

12 All

01 4Y

02 8Blank

filter Expiration Date Reset all filters

12 All

01 42032-11-19

02 42033-01-10

03 42034-05-12

Product Main Page

01

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-19

HYDROCORTISONE

US Patent Number : 9717740

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-10

HYDROCORTISONE

US Patent Number : 9675559

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-05-12

HYDROCORTISONE

US Patent Number : 9649280

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-10

HYDROCORTISONE

US Patent Number : 9675559

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-05-12

HYDROCORTISONE

US Patent Number : 9649280

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-19

HYDROCORTISONE

US Patent Number : 9717740

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-19

HYDROCORTISONE

US Patent Number : 9717740

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2034-05-12

HYDROCORTISONE

US Patent Number : 9649280

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2034-05-12

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2033-01-10

HYDROCORTISONE

US Patent Number : 9675559

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2033-01-10

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

ETON

AGGSpend

Not Confirmed

ETON

AGGSpend

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2032-11-19

HYDROCORTISONE

US Patent Number : 9717740

Drug Substance Claim :

Drug Product Claim :

Application Number : 213876

Patent Use Code : U-3075

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2032-11-19

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Ask Us!